Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5212475

NC(=O)C1Cc2ccccc2N1.NCc1cccc(C(=O)N(CC(=O)O)c2ccccc2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
F2 P00734 3/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
TPSAB1 Q15661 7/20 0.34
ACHE P22303 1/20 0.33
ADRA2C P18825 1/20 0.33
FOLH1 Q04609 2/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
F10 P00742 1/20 0.32
CPB2 Q96IY4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7426888 0.95 GAA (0.37) GAAMAPTF2PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL8029942 0.90 MAPT (0.43) GAAMAPTF2PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL5210906 0.78 ACHE (0.39) F2PRSS1PRSS2PRSS3ACHE
Trifluoroacetic Acid SCHEMBL5216054 0.77 ACHE (0.38) MAPTF2PRSS1PRSS2PRSS3
SCHEMBL5210877 0.77 ADRA2C (0.52) GAAF2ACHEADRA2C
Trifluoroacetic Acid SCHEMBL5210467 0.77 F2 (0.37) F2PRSS1PRSS2PRSS3ADRA2C
Trifluoroacetic Acid SCHEMBL5214692 0.75 MAOA (0.35) F2PRSS1PRSS2PRSS3ADRA2C
Trifluoroacetic Acid SCHEMBL5213937 0.75 F2 (0.34) F2PRSS1PRSS2PRSS3TPSAB1
Trifluoroacetic Acid SCHEMBL5206988 0.74 FOLH1 (0.35) F2PRSS1PRSS2PRSS3TPSAB1
Trifluoroacetic Acid SCHEMBL5209705 0.74 F2 (0.33) F2PRSS1PRSS2PRSS3TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1240154-B1 SERINE PROTEASE INHIBITORS TULARIK LTD (GB) 2007-02-28 EP disclosed
US-7157585-B2 Serine protease inhibitors TULARIK LIMITED (GB) 2007-01-02 US disclosed
US-20050215587-A1 Serine protease inhibitors LIVELY SARAH E 2005-09-29 US disclosed
US-6916957-B2 Serine protease inhibitors TULARIK LIMITED (GB) 2005-07-12 US disclosed
US-20030018059-A1 Serine protease inhibitors PROTHERICS MOLECULAR DESIGN LIMITED (GB) 2003-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215587-A1 Serine protease inhibitors PRSS1, TPSAB1, CMA1 GAA 684/4885MAPT 4112/4885F2 69/4885
US-20030018059-A1 Serine protease inhibitors TPSAB1, PRSS1, SERPINB1 GAA 843/4885MAPT 4440/4885F2 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.